25 Years on—an update on topics selected from the first volume of the Journal

References

1. Turk DC, May JR. Haemophilus influenzae: its clinical importance London: English Universities Press; 1967
   [Google Scholar]
2. Turk DC, Holdaway MD. Capsulated Haemophilus influenzae and bronchiectasis. J Med Microbiol 1968; 1:79–88
   [Google Scholar]
3. Moxon ER, Kroll JS. The role of bacterial polysaccharide capsules as virulence factors. Curr Top Microbiol Immunol 1990; 150:65–86
   [Google Scholar]
4. Kroll JS, Hopkins I, Moxon ER. Capsule loss in H. influenzae type b occurs by recombination-mediated disruption of a gene essential for polysaccharide export. Cell 1988; 53:347–356
   [Google Scholar]
5. Barbour ML, Crook DW, Mayon-White RT. An improved antiserum agar method for detecting carriage of Haemophilus influenzae type b. Eur J Clin Microbiol Infect Dis 1993; 12:215–217
   [Google Scholar]
6. Kroll JS, Zamze S, Loynds B, Moxon ER. Common organization of chromosomal loci for production of different capsular polysaccharides in Haemophilus influenzae. J Bacteriol 1989; 171:3343–47
   [Google Scholar]
7. Falla TJ. Molecular epidemiology of Haemophilus influenzae PhD Thesis University of Wales; 1993
   [Google Scholar]
8. Kroll JS, Loynds BM, Moxon ER. The Haemophilus influenzae capsulation gene cluster: a compound transposon. Mol Microbiol 1991; 5:1549–1560
   [Google Scholar]
9. van-Ketel RJ, de Wever B, van Alphen L. Detection of Haemophilus influenzae in cerebrospinal fluids by polymerase chain reaction DNA amplification. J Med Microbiol 1990; 33:271–276
   [Google Scholar]
10. Pennington TH. Haemophilus species and clones. Rev Med Microbiol 1993; 4:50–58
    [Google Scholar]
11. Jordens JZ, Leaves NI, Anderson EC, Slack MP. Polymerase chain reaction-based strain characterization of non-capsulate Haemophilus influenzae. J Clin Microbiol 1993; 31:2981–2987
    [Google Scholar]
12. Falla TJ, Dobson SRM, Crook DWM. et al. Population-based study of non-typable Haemophilus influenzae invasive disease in children and neonates. Lancet 1993; 341:851–854
    [Google Scholar]
13. Slack MPE, Crook DWM, Jordens JZ. et al. Molecular and epidemiological aspects of Haemophilus influenzae infection. PHLS Microbiol Dig 1993; 10:122–128
    [Google Scholar]
14. Hansman D. The epidemiology of invasive Haemophilus influenzae infections in children under five years of age in the Northern Territory: a three year study. Med J Aust 1990; 153:115–116
    [Google Scholar]
15. Lehmann D. Epidemiology of acute respiratory tract infections, especially those due to Haemophilus influenzae, in Papua New Guinean children. J Infect Dis 1992; 165:Suppl 1S20–S25
    [Google Scholar]
16. Green BA, Vazquez ME, Zlotnick GW. et al. Evaluation of mixtures of purified Haemophilus influenzae outer membrane proteins in protection against challenge with nontypeable H. influenzae in the chinchilla otitis media model. Infect Immun 1993; 61:1950–1957
    [Google Scholar]
17. Holt LB, Spasojevíc V. The role of surface antigens in the protective potency of Bordetella pertussis suspensions as measured by the intracerebral challenge technique in mice. J Med Microbiol 1968; 1:119–126
    [Google Scholar]
18. Wardlaw AC, Hall E, Parton R. Coughing rat model of pertussis. Biologicals 1993; 21:27–29
    [Google Scholar]
19. Hall E, Parton R, Wardlaw AC. Cough production, leukocytosis and serology of rats infected intrabronchially with Bordetella pertussis. J Med Microbiol 1994; 40:205–213
    [Google Scholar]
20. Parton R, Hall E, Wardlaw AC. Responses to Bordetella pertussis mutant strains and to vaccination in the coughing rat model of pertussis. J Med Microbiol 1994; 40:307–312
    [Google Scholar]
21. Miller E. Current epidemiology of pertussis in the U.K. Biologicals 1993; 21:10–11
    [Google Scholar]
22. Fine PEM. Epidemiological considerations for whooping cough eradication. Wardlaw AC, Parton R. (eds) Pathogenesis and immunity in pertussis Chichester: Wiley; 1988451–467
    [Google Scholar]
23. Cherry JD, Brunell PA, Golden GS, Karzon DT. Report of the task force on pertussis and pertussis immunization—1988. Pediatrics 1988; 81: Suppl 939–984
    [Google Scholar]
24. Marcuse EK, Wentz KR. The NCES reconsidered: summary of a 1989 workshop. National Childhood Encephalopathy Study. Vaccine 1990; 8:531–535
    [Google Scholar]
25. Cowan LD, Griffin MR, Howson CP. et al. Acute encephalopathy and chronic neurological damage after pertussis vaccine. Vaccine 1993; 11:1371–1379
    [Google Scholar]
26. Communicable Diseases and Environmental Health in Scotland Weekly Report 1993; 27: No. 93/461–2
    [Google Scholar]
27. Muller AS, Leeuwenburg J, Pratt DS. Pertussis: epidemiology and control. Bull WHO 1986; 64:321–331
    [Google Scholar]
28. Sato Y, Sato H. Animal models of pertussis. Wardlaw AC, Parton R. (eds) Pathogenesis and immunity in pertussis Chichester: Wiley; 1988309–325
    [Google Scholar]
29. Wardlaw AC. Multiple discontinuity as a remarkable feature of the development of acellular pertussis vaccines. Vaccine 1992; 10:643–651
    [Google Scholar]
30. Weiss AA, Falkow S. The use of molecular techniques to study microbial determinants of pathogenicity. Philos Trans R Soc Lond [Biol] 1983; 303:219–255
    [Google Scholar]
31. Ui M. The multiple biological activities of pertussis toxin. Furman BL, Sidney FM, Smith M. Metabolic disturbances produced by pertussis toxin. Munoz JJ. Action of pertussigen (pertussis toxin) on the host immune system. Wardlaw AC, Parton R. (eds) Pathogenesis and immunity in pertussis Chichester: Wiley; 1988121–145 147–172; 173–192
    [Google Scholar]
32. Parton R. Changing perspectives on pertussis and pertussis vaccination. Rev Med Microbiol 1991; 2:121–128
    [Google Scholar]
33. Burns DL. Subunit structure and enzymic activity of pertussis toxin. Microbiol Sci 1988; 5:285–287
    [Google Scholar]
34. Locht C, Keith JM. Pertussis toxin gene: nucleotide sequence and genetic organization. Science 1986; 232:1258–1264
    [Google Scholar]
35. Nicosia A, Perugini M, Franzini C. et al. Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. Proc Natl Acad Sci USA 1986; 83:4631–4635
    [Google Scholar]
36. Rappuoli R, Pizza M, Podda A, de Magistris MT, Nencioni L. Towards third-generation whooping cough vaccines. Tibtech 1991; 9:232–238
    [Google Scholar]
37. Hewlett EL, Cherry JD. New and improved vaccines against pertussis. Woodrow GC, Levine MM. (eds) New generation vaccines New York: Marcel Dekker; 1990231–250
    [Google Scholar]
38. Sato Y, Kimura M, Fukumi H. Development of a pertussis component vaccine in Japan. Lancet 1984; 1:122–126
    [Google Scholar]
39. Ad hoc group for the study of pertussis vaccines Placebo-controlled trial of two acellular pertussis vaccines in Sweden—protective efficacy and adverse events. Lancet 1988; 1:955–960
    [Google Scholar]
40. Coote JG. Antigenic switching and pathogenicity: environmental effects on virulence gene expression in Bordetella pertussis. J Gen Microbiol 1991; 137:2493–2503
    [Google Scholar]
41. Preston NW. Pertussis today. Wardlaw AC, Parton R. (eds) Pathogenesis and immunity in pertussis Chichester: Wiley; 19881–18
    [Google Scholar]
42. Friedman RL, Nordensson K, Wilson L, Akporiage ET, Yocum DE. Uptake and intracellular survival of Bordetella pertussis in human macrophages. Infect Immun 1992; 60:4578–4585
    [Google Scholar]
43. Porter JF, Connor K, Donachie W. Isolation and characterization of Bordetella parapertussis-like bacteria from ovine lungs. Microbiology 1994; 140:255–261
    [Google Scholar]
44. Porter JF, Parton R, Wardlaw AC. Growth and survival of Bordetella bronchiseptica in natural waters and in buffered saline without added nutrients. Appl Environ Microbiol 1991; 57:1202–1206
    [Google Scholar]
45. Hornibrook JW, Ashburn LL. A study of experimental pertussis in the young rat. Public Health Rep 1939; 54:439–444
    [Google Scholar]
46. Woods DE, Franklin R, Cryz SJ, Gauss M, Peppier M, Ewanowich C. Development of a rat model for respiratory infection with Bordetella pertussis. Infect Immun 1989; 57:1018–1024
    [Google Scholar]
47. Pittman M. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. Rev Infect Dis 1979; 1:401–412
    [Google Scholar]
48. Smith HW, Linggood MA. Observation on the pathogenic properties of the K88, Hly and Ent plasmids of Escherichia coli with particular reference to porcine diarrhoea. J Med Microbiol 1971; 141:467–485
    [Google Scholar]
49. Pickett CL, Twiddy EM, Belisle BW, Holmes RK. Cloning of genes that encode a new heat-labile enterotoxin of Escherichia coli. J Bacteriol 1986; 165:348–352
    [Google Scholar]
50. Harnett NM, Gyles CL. Enterotoxin plasmids in bovine and porcine enterotoxigenic Escherichia coli of O groups 9, 20, 64 and 101. Can J Comp Med 1985; 49:79–87
    [Google Scholar]
51. Konowalchuk J, Speirs JI, Stavric S. Vero response to a cytotoxin of Escherichia coli. Infect Immun 1977; 18:775–779
    [Google Scholar]
52. Smith HW, Green P, Parsell Z. Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens and pigs. J Gen Microbiol 1983; 129:3121–3137
    [Google Scholar]
53. Gannon VP, Gyles CL, Wilcock BP. Effects of Escherichia coli Shiga-like toxins (verotoxins) in pigs. Can J Vet Res 1989; 53:306–312
    [Google Scholar]
54. Caprioli A, Falbo V, Roda LG, Ruggeri FM, Zona C. Partial purification and characterization of an Escherichia coli toxic factor that induces morphological cell alterations. Infect Immun 1983; 39:1300–1306
    [Google Scholar]
55. Holland RE. Some infectious causes of diarrhea in young farm animals. Clin Microbiol Rev 1990; 3:345–375
    [Google Scholar]
56. De Rycke J, Gonzales EA, Blanco J, Oswald E, Blanco M, Boivin R. Evidence for two types of cytotoxic necrotising factor in human and animal clinical isolates of Escherichia coli. J Clin Microbiol 1990; 28:694–699
    [Google Scholar]
57. Falbo V, Famiglietti M, Carpioli A. Gene block encoding production of cytotoxic necrotising factor 1 and hemolysin in Escherichia coli isolates from extraintestinal infections. Infect Immun 1992; 60:2182–2187
    [Google Scholar]
58. Smith HW. A search for transmissible pathogenic characters in invasive strains of Escherichia coli: the discovery of a plasmid-controlled toxin and a plasmid-controlled lethal character closely associated or identical with colicine V. J Gen Microbiol 1974; 83:95–111
    [Google Scholar]
59. Moon HW. Colonisation factor antigens of enterotoxigenic Escherichia coli in animals. Curr Top Microbiol Immunol 1990; 151:147–165
    [Google Scholar]
60. Yano T, Leite Dda S, de Carmargo IJB, Pestano de Castro AF. A probable new adhesive factor (F42) produced by enterotoxigenic Escherichia coli isolated from pigs. Microbiol Immunol 1986; 30:495–508
    [Google Scholar]
61. Girardeau J-P, Dubourguier HC, Contrepois M. Attachement des E. coli enteropathogènes à la muqueuse intestinale Bull. GTV 1980; 4B:19049
    [Google Scholar]
62. Bertschinger HU, Bachmann M, Mettler C. et al. Adhesive fimbriae produced in vivo by Escherichia coli O139: K12 (B):H1 associated with enterotoxaemia in pigs. Vet Microbiol 1990; 25:267–281
    [Google Scholar]
63. Fairbrother JM, Lariviere S, Lallier R. New fimbrial antigen FI65 from Escherichia coli serogroup 0115 strains isolated from piglets with diarrhea. Infect Immun 1986; 51:10–15
    [Google Scholar]
64. Girardeau JP, Der Vartanian M, Oilier JL, Contrepois M. CS31A, a new K88-related fimbrial antigen on bovine enterotoxigenic and septicemic Escherichia coli strains. Infect Immun 1988; 56:2180–2188
    [Google Scholar]
65. Aning KG, Thomlinson JR, Wray C, Sojka WJ, Coulter J. Adhesion factor distinct from K88, K99, F41, 987P, CFAI and CFAII in porcine Escherichia coli. Vet Rec 1983; 112:251
    [Google Scholar]
66. Salajka E, Salajkova Z, Alexa P, Hornich M. Colonisation factor different from K88, K99, F41 and 987P in enterotoxigenic Escherichia coli strains isolated from postweaning diarrhea in pigs. Vet Microbiol 1992; 32:163–175
    [Google Scholar]
67. Varga J. Characterization of a new fimbrial antigen present in Escherichia coli strains isolated from calves. Zentralbl Veterinarmed B 1991; 38:689–700
    [Google Scholar]
68. van den Bosch JF, Hendriks JH, Gladigau I, Willems HM, Storm PK, de Graaf FK. Identification of F11 fimbriae on chicken Escherichia coli strains. Infect Immun 1993; 61:800–806
    [Google Scholar]
69. Sellwood R, Gibbons RA, Jones GW, Rutter JM. Adhesion of enteropathogenic Escherichia coli to pig intestinal brush borders: the existence of two pig phenotypes. J Med Microbiol 1975; 8:405–411
    [Google Scholar]
70. Bertschinger HU, Stamm M, Vogeli P. Inheritance of resistance to oedema disease in the pig: experiments with an Escherichia coli strain expressing fimbriae 107. Vet Microbiol 1993; 35:79–89
    [Google Scholar]
71. Olsen A, Jonsson A, Normak S. Fibronectin binding mediated by a novel class of surface organelles on Escherichia coli. Nature 1989; 338:652–655
    [Google Scholar]
72. Wray C, Morris JA. Aspects of colibacillosis in farm animals. J Hyg 1985; 95:577–593
    [Google Scholar]
73. Tesh VL, O'Brien AD. Adherence and colonization mechanisms of enteropathogenic and enterohemorrhagic Escherichia coli. Microb Pathog 1992; 12:245–254
    [Google Scholar]
74. Wray C, McLaren IM, Carroll PJ. Escherichia coli isolated from farm animals in England and Wales between 1986 and 1991. Vet Rec 1993; 133:439–442
    [Google Scholar]
75. Tokhi AM, Peiris JS, Scotland SM, Willshaw GA, Smith HR, Cheasty T. A longitudinal study of Vero cytotoxin producing Escherichia coli in cattle calves in Sri Lanka. Epidemiol Infect 1993; 110:197–208
    [Google Scholar]
76. Mainil JG, Jacquemin ER, Kaeckenbeeck AE, Pohl PH. Association between the effacing (eae) gene and the Shiga-like toxin-encoding genes in Escherichia coli isolates from cattle. Am J Vet Res 1993; 54:1064–1068
    [Google Scholar]
77. Karmali MA. Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 1989; 2:15–38
    [Google Scholar]
78. Chapman PA, Wright DJ, Norman P. Verotoxin-producing Escherichia coli infections in Sheffield: cattle as a possible source. Epidemiol Infect 1989; 102:439–445
    [Google Scholar]
79. Synge BA, Hopkins GF. Verotoxigenic Escherichia coli O157 in Scottish calves. Vet Rec 1992; 130:583
    [Google Scholar]
80. Lyell A, Dick HM, Alexander J O’D. Outbreak of toxic epidermal necrolysis associated with staphylococci. Lancet 1969; 1:787–789
    [Google Scholar]
81. Arbuthnott JP, Gemmell CG, Kent J, Lyell A. Haemolysin and enzyme patterns of coagulase-positive staphylococci isolated from toxic epidermal necrolysis, Ritter’s disease and impetigo contagiosa. J Med Microbiol 1969; 2:479–487
    [Google Scholar]
82. Arbuthnott JP, Kent J, Lyell A, Gemmell CG. Toxic epidermal necrolysis produced by an extracellular product of Staphylococcus aureus. B J Dermatol 1971; 85:145–149
    [Google Scholar]
83. Melish ME, Glasgow LA. The staphylococcal scalded skin syndrome: development of an experimental model. New Engl J Med 1970; 282:1114–1119
    [Google Scholar]
84. Lillibridge CG, Melish ME, Glasgow LA. Site of action of exfoliative toxin in the staphylococcal scalded-skin syndrome. Pediatrics 1972; 50:728–738
    [Google Scholar]
85. Shands KN, Schmid GP, Dan BB. et al. Toxic-shock syndrome in menstruating women. N Engl J Med 1980; 303:1436–1442
    [Google Scholar]
86. Bergdoll MS, Crass BA, Reiser RF, Robbins RN, Davis JP. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet 1981; 1:1017–1021
    [Google Scholar]
87. Schlievert PM, Shands KN, Dan BB, Schmid GP, Nishimura RD. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic shock syndrome. J Infect Dis 1981; 143:509–516
    [Google Scholar]
88. Arbuthnott JP, Coleman DC, de Azavedo JS. Staphylococcal toxins in human disease. Soc Appl Bacteriol Symp 1990; 19:101S–107S
    [Google Scholar]
89. Marples RR, Wieneke AA. Enterotoxins and toxic shock syndrome toxin-1 in non-enteric staphylococcal disease. Epidemiol Infect 1993; 110:477–488
    [Google Scholar]
90. Schlievert PM. Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet 1986; 1:1149–1150
    [Google Scholar]
91. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990; 248:705–711
    [Google Scholar]
92. Drake CG, Kotzin BL. Superantigens: biology, immunology, and potential role in disease. J Clin Immunol 1992; 12:149–162
    [Google Scholar]
93. Leung DYM. Kawasaki disease. Curr Opin Rheumatol 1993; 5:41–50
    [Google Scholar]
94. Leung DYM, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993; 342:1385–1388
    [Google Scholar]
95. Bayston R. Serological investigations in children with colonized Spitz-Holter valves. J Clin Pathol 1972; 25:718–720
    [Google Scholar]
96. Winston DJ, Dudnick DV, Chapin M, Ho WG, Gale RP, Martin WJ. Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med 1983; 143:32–36
    [Google Scholar]
97. Gemmell CG, Roberts E. Toxins and enzymes of coagulase-negative staphylococci isolated from human infections. J Hyg Epidemiol Microbiol Immunol 1974; 18:276–280
    [Google Scholar]
98. Gemmell CG, Thelestam M. Toxinogenicity of clinical isolates of coagulase-negative staphylococci towards various animal cells. Acta Pathol Microbiol Scand Sect B 1981; 89:417–421
    [Google Scholar]
99. Christensen GD, Simpson WA, Bisno AL, Beachey EH. Adherence of slime-producing strains of Staphylococcus epìdermidis to smooth surfaces. Infect Immun 1982; 37:318–326
    [Google Scholar]
100. Hussain M, Hastings JGM, White PJ. Comparison of cell wall teichoic acid with high molecular weight extracellular slime material from Staphylococcus epidermidis. J Med Microbiol 1992; 37:368–375
     [Google Scholar]
101. Gray ED, Peters G, Verstegen M, Regelmann WE. Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet 1984; 1:365–367
     [Google Scholar]
102. Long JP, Hart J, Albers W, Kapral FA. The production of fatty acid modifying enzyme (FAME) and lipase by various staphylococcal species. J Med Microbiol 1992; 37:232–234
     [Google Scholar]
103. Mortensen JE, Shryock TR, Kapral FA. Modification of bactericidal fatty acids by an enzyme of Staphylococcus aureus. J Med Microbiol 1992; 36:293–298
     [Google Scholar]
104. Kapral FA, Smith S, Lai D. The esterification of fatty acids by Staphylococcus aureus fatty acid modifying enzyme (FAME) and its inhibition by glycerides. J Med Microbiol 1992; 37:235–237
     [Google Scholar]
105. Musser JM, Schlievert PM, Chow AW. et al. A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc Natl Acad Sci USA 1990; 87:225–229
     [Google Scholar]
106. Foster TJ. The use of mutants for defining the role of virulence factors in vivo. Hormaeche CE, Penn CW, Smyth CJ. (eds) Molecular biology of bacterial infection: current status and future perspectives. Soc Gen Microbiol Sym 49: 1992173–191
     [Google Scholar]
107. Scott JM, Henderson A. A case of listeriosis of the newborn. J Med Microbiol 1968; 1:97–104
     [Google Scholar]
108. Murray EGD, Webb RA, Swann MBR. A disease of rabbits characterised by a large mononuclear leucocytosis, caused by a hitherto underscribed bacillus Bacterium monocytogenes. J Pathol Bacteriol 1926; 29:407–439
     [Google Scholar]
109. Gray ML, Killinger AH. Listeria monocytogenes and listeric infections Bacteriol Rev 1966; 30:309–382
     [Google Scholar]
110. Burn CG. Clinical and pathological features of an infection caused by a new pathogen of the genus Listerella. Am J Pathol 1936; 12:341–348
     [Google Scholar]
111. Weis J, Seeliger HPR. Incidence of Listeria monocytogenes in nature. Appl Microbiol 1975; 30:29–32
     [Google Scholar]
112. Rocourt J, Grimont F, Grimont PAD, Seeliger HPR. DNA relatedness among serovars of Listeria monocytogenes sensu lato. Curr Microbiol 1982; 7:383–388
     [Google Scholar]
113. Rocourt J, Catimel B. Caracterisation biochimique des especes du genre Listeria. Zentralbl Bakteriol Mikrobiol Hyg A 1985; 260:221–231
     [Google Scholar]
114. Jones D, Feresu S, Collins MD. Classification and identification of Listeria, Brochothrix and Erysiplothrix. Courtieu AL, Espaze EP, Reynaud AE. (eds) Listeriose, Listeria , Listeriosis Nantes: Université de Nantes; 1986
     [Google Scholar]
115. Lamont RJ, Petrie DT, Melvin WT, Postlethwaite R. An investigation of taxonomy of Listeria species by comparison of electrophoretic protein patterns. Courtieu AL, Espaze EP, Reynaud AE. (eds) Listeriose, Listeria Listeriosis Nantes: Université de Nantes; 1986
     [Google Scholar]
116. Fiedler F. Biochemistry of the cell surface of Listeria strains: a locating general view. Infection 1988; 16:Suppl 2S92–S97
     [Google Scholar]
117. Schrettenbrunner A, Schroter G, Rocourt J. Antibiotic susceptibility of the genus Listeria. Courtieu AL, Espaze EP, Reynaud AE. (eds) Listeriose, Listeria, Listeriosis Nantes: Université de Nantes; 1986
     [Google Scholar]
118. Mainou-Fowler T, MacGowan AP, Postlethwaite R. Virulence of Listeria spp: course of infection in resistant and susceptible mice. J Med Microbiol 1988; 27:131–140
     [Google Scholar]
119. MacGowan AP, Holt HA, Bywater MJ, Reeves DS. In vitro antimicrobial susceptibility of Listeria monocytogenes isolated in the UK and other Listeria species. Eur J Clin Microbiol Infect Dis 1990; 9:767–770
     [Google Scholar]
120. MacGowan AP, O’Donaghue K, Nicholls S, McLauchlin J, Bennet PM, Reeves DS. Typing of Listeria spp. by random amplified polymorphic DNA (RAPD) analysis. J Med Microbiol 1993; 38:322–327
     [Google Scholar]
121. McLauchlin J. Listeria monocytogenes, recent advances in the taxonomy and epidemiology of listeriosis in humans. J Appl Bacteriol 1987; 63:1–11
     [Google Scholar]
122. Rocourt J, Hof H, Schrettenbrunner A, Malinverni R, Bille J. Meningite purulente aigue a Listeria seeligeri chez un adulte immunocompetent. Schweiz Med Wochenschr 1986; 116:248–251
     [Google Scholar]
123. Paterson JS. Flagellar antigens of organisms of the genus Listerella. J Pathol Bacteriol 1939; 48:25–32
     [Google Scholar]
124. Seeliger HPR, Höhne K. Serotyping of Listeria monocytogenes and related species. Bergan T, Norris JR. (eds) Methods in microbiology London: Academic Press; 1979 13 31–49
     [Google Scholar]
125. Ralovich B, Ewan EP, Emody L. Alteration of phage- and biotypes of Listeria strains. Acta Microbiol Hung 1986; 33:19–26
     [Google Scholar]
126. Audurier A, Rocourt J, Courtieu AL. Phage typing systems for Listeria monocytogenes. Ivanov I. (ed) Seventh international symposium on problems in listeriosis Sofia: National Agroindustrial Union Center for Scientific Information;108–121
     [Google Scholar]
127. Bibb WF, Schwartz B, Gellin BG, Plikaytis BD, Weaver RE. Analysis of Listeria monocytogenes by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Int J Food Microbiol 1989; 8:233–239
     [Google Scholar]
128. Fistrovicia E, Collins-Thompson DL. Use of plasmid profiles and restriction endonuclease digest in environmental studies of Listeria spp. from raw milk. Int J Food Microbiol 1990; 10:43–50
     [Google Scholar]
129. Wilhelms D, Sandow D. Preliminary studies on monocine typing of Listeria monocytogenes strains. Acta Microbiol Hung 1989; 36:235–238
     [Google Scholar]
130. Pérez-Díaz JC, Vincente MF, Baquero F. Plasmids in Listeria. Plasmid 1982; 8:112–118
     [Google Scholar]
131. Saunders NA, Ridley AM, Taylor AG. Typing of Listeria monocytogenes for epidemiological studies using DNA probes. Acta Microbiol Hung 1989; 36:205–209
     [Google Scholar]
132. McLauchlin J, Audurier A, Taylor AG. The evaluation of a phage-typing system for Listeria monocytogenes for use in epidemiological studies. J Med Microbiol 1986; 22:357–365
     [Google Scholar]
133. Schlech WF. Listeriosis: epidemiology, virulence and the significance of contaminated foodstuffs. J Hosp Infect 1991; 19:211–224
     [Google Scholar]
134. Ciesielski CA, Hightower AW, Parsons SK, Broome CV. Listeriosis in the United States: 1980–1982. Arch Intern Med 1988; 148:1416–1419
     [Google Scholar]
135. Frederiksen B, Samuelsson S. Feto-maternal listeriosis in Denmark 1981–1988. J Infect 1992; 24:277–287
     [Google Scholar]
136. Newton L, Hall SM, McLauchlin J. Listeriosis surveillance: 1992. Commun Dis Rep CDR Rev 1993; 3:R144–R146
     [Google Scholar]
137. McLauchlin J, Hall SM, Velani SK, Gilbert RJ. Human listeriosis and paté: a possible association. BMJ 1991; 303:773–775
     [Google Scholar]
138. Schlech WF, Lavigne PM, Bortolussi RA. Epidemic listeriosis—evidence for transmission by food. N Engl J Med 1983; 308:203–206
     [Google Scholar]
139. Flemming DW, Cochi SL, MacDonald KL. et al. Pasteurized milk as a vehicle of infection in an outbreak of listeriosis. N Engl J Med 1985; 312:40–407
     [Google Scholar]
140. Bille J, Rocourt J, Mean F. Epidemic food borne listeriosis in western Switzerland. 28th ICAAC1988 abstract no. 1107
     [Google Scholar]
141. Schwartz B, Hexter D, Broome CV. et al. Investigation of an outbreak of listeriosis: new hypotheses for the etiology of epidemic Listeria monocytogenes infections. J Infect Dis 1989; 159:680–685
     [Google Scholar]
142. Schwartz B, Ciesielski CA, Broome CV. et al. Association of sporadic listeriosis with consumption of uncooked hot dogs and undercooked chicken. Lancet 1988; 2:779–782
     [Google Scholar]
143. Bannister BA. Listeria monocytogenes meningitis associated with eating soft cheese. J Infect 1987; 15:165–168
     [Google Scholar]
144. Kerr KG, Dealler SF, Lacey RW. Materno-fetal listeriosis from cook-chill and refrigerated food. Lancet 1988; 2:1133
     [Google Scholar]
145. Azadian BS, Finnerty GT, Pearson AD. Cheese-borne Listeria meningitis in an immunocompetent patient. Lancet 1989; 1:322–323
     [Google Scholar]
146. Morris IJ, Ribeiro CD. The occurrence of Listeria species in pâté: the Cardiff experience 1989. Epidemiol Infect 1991; 107:111–117
     [Google Scholar]
147. Pini PN, Gilbert RJ. The occurrence in the UK of Listeria species in raw chickens and soft cheeses. Int J Food Microbiol 1988; 6:317–326
     [Google Scholar]
148. MacGowan AP, Bowker K, McLauchlin J, Bennett PM, Reeves DS. The occurrence and seasonal changes in the isolation of Listeria spp. in shop bought food stuffs, human faeces, sewage and soil from urban sources. Int J Food Microbiol (in press)
     [Google Scholar]
149. Breer C, Schopfer K. Listeria and food. Lancet 1988; 2:1022
     [Google Scholar]
150. Sepp AH, Roy TE. Listeria monocytogenes infections in metropolitan Toronto: a clinicopathological study. Can Med Ass J 1963; 88:549–561
     [Google Scholar]
151. McLauchlin J. Human listeriosis in Britain, 1967–1985, a summary of 722 cases. 2. Listeriosis in non-pregnant individuals, a changing pattern of infection and seasonal incidence. Epidemiol Infect 1990; 104:191–201
     [Google Scholar]
152. Newton L, Hall SM, Pelevin M, McLauchlin J. Listeriosis surveillance: 1990. Commun Dis Rep CDR Rev 1991; 1:R110–R143
     [Google Scholar]
153. McLauchlin J. Human listeriosis in Britain, 1967–85, a summary of 722 cases. 1. Listeriosis during pregnancy and in the newborn. Epidemiol Infect 1990; 104:181–189
     [Google Scholar]
154. Larsson S. Epidemiology of listeriosis in Sweden 1958–1974. Scand J Infect Dis 1979; 11:47–54
     [Google Scholar]
155. Nieman RE, Lorber B. Listeriosis in adults: a changing pattern. Report of eight cases and review of the literature, 1968–1978. Rev Infect Dis 1980; 2:207–227
     [Google Scholar]
156. Pollock SS, Pollock TM, Harrison MJG. Infection of the central nervous system by Listeria monocytogenes: a review of 54 adult and juvenile cases. Q J Med 1984; 53:331–340
     [Google Scholar]
157. Louria DB, Blevins A, Armstrong D. Listeria infections. Ann NY Acad Sci 1970; 174:545–551
     [Google Scholar]
158. Samra Y, Hertz M, Altmann G. Adult Listeriosis—a review of 18 cases. Postgrad Med J 1984; 60:267–269
     [Google Scholar]
159. Jurado RL, Farley MM, Pereira E. et al. Increased risk of meningitis and bacteremia due to Listeria monocytogenes in patients with human immunodeficiency virus infection. Clin Infect Dis 1993; 17:224–227
     [Google Scholar]
160. Bo Hansen P, Jensen TH, Lykkegaard S, Kristensen HS. Listeria monocytogenes meningitis in adults. Sixteen consecutive cases 1973–1982. Scand J Infect Dis 1987; 19:55–60
     [Google Scholar]
161. MacNair DR, White JE, Graham JM. Ampicillin in the treatment of Listeria monocytogenes meningitis. Lancet 1968; 1:16–18
     [Google Scholar]
162. Lavetter A, Leedom JM, Mathies AW, Ivler D, Wehrle PF. Meningitis due to Listeria monocytogenes. A review of 25 cases. N Engl J Med 1971; 285:598–603
     [Google Scholar]
163. Larsson S, Cronberg S, Winblad S. Clinical aspects on 64 cases of juvenile and adult listeriosis in Sweden. Acta Med Scand 1978; 204:503–508
     [Google Scholar]
164. Cherubin CE, Appleman MD, Heseltine PN, Khayr W, Stratton CW. Epidemiological spectrum and current treatment of listeriosis. Rev Infect Dis 1991; 13:1108–1114
     [Google Scholar]
165. Moellering RC, Medoff G, Leech I, Wennersten C, Kunz LJ. Antibiotic synergism against Listeria monocytogenes. Antimicrob Agents Chemother 1972; 1:30–34
     [Google Scholar]
166. MacGowan AP, Holt HA, Reeves DS. In-vitro synergy testing of nine antimicrobial combinations against Listeria monocytogenes. J Antimicrob Chemother 1990; 25:561–566
     [Google Scholar]
167. Poyart-Salmeron C, Carlier C, Trieu-Cuot P, Courtieu A-L, Courvalin P. Transferable plasmid-mediated antibiotic resistance in Listeria monocytogenes. Lancet 1990; 335:1422–1426
     [Google Scholar]
168. MacGowan AP, Reeves DS, McLauchlin J. Antibiotic resistance of Listeria monocytogenes. Lancet 1990; 336:513–514
     [Google Scholar]
169. Trautmann M, Wagner J, Chahin M, Weinke T. Listeria meningitis: report of ten recent cases and review of current therapeutic recommendations. J Infect 1985; 10:107–114
     [Google Scholar]
170. Stamm AM, Dismukes WE, Simmons BP. et al. Listeriosis in renal transplant recipients: report of an outbreak and review of 102 cases. Rev Infect Dis 1982; 4:665–682
     [Google Scholar]
171. Cherubin CE. Questions about Listeria monocytogenes susceptibility testing. Infect Dis Newsletter 1992; 11:19–21
     [Google Scholar]
172. Cherubin CE, Marr JS, Sierra MF, Becker S. Listeria and gram-negative bacillary meningitis in New York City, 1972–1979. Frequent causes of meningitis in adults. Am J Med 1981; 71:199–209
     [Google Scholar]
173. McLauchlin J, Audurier A, Taylor AG. Treatment failure and recurrent listeriosis. J Antimicrob Chemother 1991; 27:851–857
     [Google Scholar]
174. Bouvet E, Suter F, Gibert C, Witchitz JL, Bazin C, Vachon F. Severe meningitis due to Listeria monocytogenes. A review of 40 cases in adults. Scand J Infect Dis 1982; 14:267–270
     [Google Scholar]